HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 303 filers reported holding HAEMONETICS CORP in Q1 2023. The put-call ratio across all filers is 0.58 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $24,435,274 | +1.5% | 256,414 | -9.3% | 1.37% | -0.3% |
Q2 2023 | $24,066,268 | -11.5% | 282,667 | -13.9% | 1.38% | -18.0% |
Q1 2023 | $27,182,630 | +0.6% | 328,491 | -4.4% | 1.68% | -1.8% |
Q4 2022 | $27,016,668 | -11.4% | 343,505 | -16.6% | 1.71% | -25.0% |
Q3 2022 | $30,504,000 | +10.4% | 412,046 | -2.8% | 2.28% | +18.7% |
Q2 2022 | $27,639,000 | -0.6% | 424,046 | -3.6% | 1.92% | +11.4% |
Q1 2022 | $27,801,000 | +29.0% | 439,746 | +8.3% | 1.72% | +36.5% |
Q4 2021 | $21,544,000 | -13.9% | 406,192 | +14.6% | 1.26% | -16.3% |
Q3 2021 | $25,019,000 | +7.6% | 354,432 | +1.5% | 1.51% | +11.9% |
Q2 2021 | $23,260,000 | +213.2% | 349,042 | +110.9% | 1.35% | +180.8% |
Q3 2017 | $7,426,000 | +13.6% | 165,494 | 0.0% | 0.48% | +14.3% |
Q2 2017 | $6,535,000 | -35.0% | 165,494 | -33.2% | 0.42% | -31.5% |
Q1 2017 | $10,048,000 | -28.9% | 247,674 | -29.5% | 0.61% | -21.4% |
Q4 2016 | $14,123,000 | -3.4% | 351,314 | -13.0% | 0.78% | -7.1% |
Q3 2016 | $14,627,000 | +95.1% | 403,940 | +56.2% | 0.84% | +99.1% |
Q2 2016 | $7,498,000 | – | 258,655 | – | 0.42% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BEACONLIGHT CAPITAL, LLC | 95,033 | $8,511,000 | 2.84% |
Advantage Alpha Capital Partners LP | 100,170 | $8,971,000 | 2.10% |
Nitorum Capital, L.P. | 395,635 | $35,433,000 | 1.82% |
Summit Creek Advisors LLC | 127,600 | $11,428,000 | 1.68% |
Bridge City Capital, LLC | 40,559 | $3,632,000 | 1.67% |
AEGON ASSET MANAGEMENT UK PLC | 520,408 | $46,603,000 | 1.05% |
Jackson Square Partners, LLC | 2,298,190 | $205,825,000 | 1.03% |
Parkman Healthcare Partners LLC | 30,147 | $2,700,000 | 0.76% |
TEALWOOD ASSET MANAGEMENT INC | 9,154 | $820,000 | 0.54% |
AMERICAN CAPITAL MANAGEMENT INC | 159,145 | $14,253,000 | 0.52% |